Literature DB >> 27566690

Pseudomonas aeruginosa ATCC 9027 is a non-virulent strain suitable for mono-rhamnolipids production.

María-Victoria Grosso-Becerra1, Abigail González-Valdez1, María-Jessica Granados-Martínez1, Estefanía Morales1, Luis Servín-González1, José-Luis Méndez2, Gabriela Delgado2, Rosario Morales-Espinosa2, Gabriel-Yaxal Ponce-Soto3, Miguel Cocotl-Yañez1, Gloria Soberón-Chávez4.   

Abstract

Rhamnolipids produced by Pseudomonas aeruginosa are biosurfactants with a high biotechnological potential, but their extensive commercialization is limited by the potential virulence of P. aeruginosa and by restrictions in producing these surfactants in heterologous hosts. In this work, we report the characterization of P. aeruginosa strain ATCC 9027 in terms of its genome-sequence, virulence, antibiotic resistance, and its ability to produce mono-rhamnolipids when carrying plasmids with different cloned genes from the type strain PAO1. The genes that were expressed from the plasmids are those coding for enzymes involved in the synthesis of this biosurfactant (rhlA and rhlB), as well as the gene that codes for the RhlR transcriptional regulator. We confirm that strain ATCC 9027 forms part of the PA7 clade, but contrary to strain PA7, it is sensitive to antibiotics and is completely avirulent in a mouse model. We also report that strain ATCC 9027 mono-rhamnolipid synthesis is limited by the expression of the rhlAB-R operon. Thus, this strain carrying the rhlAB-R operon produces similar rhamnolipids levels as PAO1 strain. We determined that strain ATCC 9027 with rhlAB-R operon was not virulent to mice. These results show that strain ATCC 9027, expressing PAO1 rhlAB-R operon, has a high biotechnological potential for industrial mono-rhamnolipid production.

Entities:  

Keywords:  Biosurfactant production; Metabolic engineering; Pseudomonas aeruginosa virulence; Quorum-sensing response

Mesh:

Substances:

Year:  2016        PMID: 27566690     DOI: 10.1007/s00253-016-7789-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  13 in total

1.  Overview on Glycosylated Lipids Produced by Bacteria and Fungi: Rhamno-, Sophoro-, Mannosylerythritol and Cellobiose Lipids.

Authors:  Susanne Zibek; Gloria Soberón-Chávez
Journal:  Adv Biochem Eng Biotechnol       Date:  2022       Impact factor: 2.635

2.  Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents.

Authors:  Matej Zore; Shella Gilbert-Girard; Inés Reigada; Jayendra Z Patel; Kirsi Savijoki; Adyary Fallarero; Jari Yli-Kauhaluoma
Journal:  ACS Omega       Date:  2021-07-09

3.  Biocontrol of Bacterial Leaf Blight of Rice and Profiling of Secondary Metabolites Produced by Rhizospheric Pseudomonas aeruginosa BRp3.

Authors:  Sumera Yasmin; Fauzia Y Hafeez; Muhammad S Mirza; Maria Rasul; Hafiz M I Arshad; Muhammad Zubair; Mazhar Iqbal
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

Review 4.  Microbial production of rhamnolipids: opportunities, challenges and strategies.

Authors:  Huiqing Chong; Qingxin Li
Journal:  Microb Cell Fact       Date:  2017-08-05       Impact factor: 5.328

Review 5.  Microbial production of rhamnolipids using sugars as carbon sources.

Authors:  Yun Nian Tan; Qingxin Li
Journal:  Microb Cell Fact       Date:  2018-06-08       Impact factor: 5.328

6.  Enhanced rhamnolipid production in Burkholderia thailandensis transposon knockout strains deficient in polyhydroxyalkanoate (PHA) synthesis.

Authors:  Scott J Funston; Konstantina Tsaousi; Thomas J Smyth; Matthew S Twigg; Roger Marchant; Ibrahim M Banat
Journal:  Appl Microbiol Biotechnol       Date:  2017-10-17       Impact factor: 4.813

7.  Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027, Originally Isolated from an Outer Ear Infection.

Authors:  Ambikesh Jayal; Benjamin E Johns; Kevin J Purdy; Sarah E Maddocks
Journal:  Genome Announc       Date:  2017-11-30

8.  Identification and characterisation of short chain rhamnolipid production in a previously uninvestigated, non-pathogenic marine pseudomonad.

Authors:  Matthew S Twigg; L Tripathi; A Zompra; K Salek; V U Irorere; T Gutierrez; G A Spyroulias; R Marchant; I M Banat
Journal:  Appl Microbiol Biotechnol       Date:  2018-07-10       Impact factor: 4.813

Review 9.  Heterologous Rhamnolipid Biosynthesis: Advantages, Challenges, and the Opportunity to Produce Tailor-Made Rhamnolipids.

Authors:  Andreas Wittgens; Frank Rosenau
Journal:  Front Bioeng Biotechnol       Date:  2020-10-22

Review 10.  Rhamnolipids produced by Pseudomonas: from molecular genetics to the market.

Authors:  Gloria Soberón-Chávez; Abigail González-Valdez; Martín P Soto-Aceves; Miguel Cocotl-Yañez
Journal:  Microb Biotechnol       Date:  2020-11-05       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.